Announcements Trials
Browse Landscape

Phase

Phase NA 58Phase 2 35Phase 1 28Phase 3 16Phase 1/2 10Phase 4 9Phase EARLY_PHASE1 7Phase 2/3 5

Status

Unknown 2Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5Thoracic 1Genitourinary 1

Conditions

Breast Neoplasms 117Neoplasms 101Prostatic Neoplasms 76Carcinoma, Non-Small-Cell Lung 75Colorectal Neoplasms 73Carcinoma, Hepatocellular 67Leukemia, Myeloid, Acute 58Stomach Neoplasms 52Neoplasm Metastasis 50Lung Neoplasms 48Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Pancreatic Neoplasms 40Recurrence 36Head and Neck Neoplasms 32Rectal Neoplasms 30Colonic Neoplasms 30Leukemia 29Multiple Myeloma 28Ovarian Neoplasms 26Lymphoma 25Squamous Cell Carcinoma of Head and Neck 24Hematologic Neoplasms 23Melanoma 22Urinary Bladder Neoplasms 20Liver Neoplasms 20Polycystic Ovary Syndrome 19Myelodysplastic Syndromes 19Lymphoma, Large B-Cell, Diffuse 19Esophageal Neoplasms 19Uterine Cervical Neoplasms 16

Interventions

Methotrexate 1Grafton demineralized bone matrix gel 1Exercise Therapy 1Etanercept 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Interventional × Bone Neoplasms × Clear all
NCT04963517 2024-12-06

proGAIT

Universität Duisburg-Essen

Phase 2/3 Completed
11 enrolled
Sarcoma

Bone Neoplasms, Motor Activity

NCT05057130 2024-04-01

Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors

Blokhin's Russian Cancer Research Center

Phase 2/3 Unknown
50 enrolled
Sarcoma

Bone Neoplasms, Neoplasms, Connective Tissue, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

NCT02302651 2014-11-27

Non-invasive Focal Therapy for Osteoid Osteoma

University of Roma La Sapienza

Phase 2/3 Unknown
60 enrolled
Sarcoma

Bone Neoplasms, Osteoma, Osteoid

NCT00851162 2012-11-28

Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions

Emory University

Phase 2/3 Withdrawn
Sarcoma

Bone Neoplasms

NCT00127387 2012-06-26

Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

The University of Texas Health Science Center at San Antonio

Phase 2/3 Terminated
54 enrolled
GenitourinarySarcomaThoracic

Bone Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡